MDCO Wins 2nd Suit Over Angiomax Patent Extension

Law360, New York (August 5, 2010, 2:08 PM EDT) -- A federal judge has ruled that the U.S. Patent and Trademark Office should find that The Medicines Co. filed its application to extend a patent for anti-coagulant Angiomax in a timely manner.

Granting summary judgment to MDCO in its second suit over the agency's rejection of the drugmaker's patent extension application, Judge Claude M. Hilton of the U.S. District Court for the Eastern District of Virginia ruled Wednesday that the USPTO should adopt an interpretation of Section 156 of the Hatch-Waxman Act that includes a next...
To view the full article, register now.